Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for cancer. Article was last updated January…
This special edition includes information on the 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule.